Gaucher disease is caused by a deficiency in the enzyme version. Both constructs are either packaged by the amphotropic virus producer cell line, PA317, 10 or the Gib-␤-glucocerebrosidase (hGC, EC 3.2.1.45). Gene therapy offers an attractive treatment for Gaucher disease since bon ape leukemia virus producer cell line, PG13, 11 to determine which retroviral receptor, GLVR-2 12 or GLVRthe clinical phenotype manifests itself predominantly in cells derived from the pluripotent hemopoietic stem cell 1, 13 is more abundantly expressed on human PHSCs. This article describes the generation and characterization of (PHSC). Transfer of a correct copy of the glucerebrosidase cDNA into PHSCs should result in hGC expressing the four retrovirus producer cell lines and the employment of these recombinant viruses for transduction of hemopoietic lineages, including macrophages. With recombinant retroviruses, up to 50-60% of human primiprimary human cells, including fibroblasts and CD34 + cells isolated from bone marrow and mobilized periphtive hemopoietic progenitor cells (CFUs) can be transduced ex vivo using clinically accepted supernatant transeral blood. In the 3Ј LTR of the retroviral constructs the enhancer in U3 of the wild-type Moloney murine leukeduction protocols.
1 However, with a few exceptions, 2, 3 the presence of transduced genes in the hemopoietic sysmia virus (MoMLV) is replaced by a mutant (PyF101) polyoma enhancer (⌬Mo + PyF101). This backbone was tem of large animals has been disappointing, with only 0.01-5% transduced cells detected in the long term. 4, 5 Facchosen since it is known that the presence of ⌬Mo + PyF101 provides sustained expression in primate tors limiting ex vivo retroviral transduction of PHSCs are now known to include virus binding, 6 ex vivo cycling and hemopoietic bone marrow cells 4 and since this hybrid LTR is known to abolish leukemogenicity of MoMLV. 14, 15 maintenance of PHSCs, 7 and amphotropic receptor expression on PHSCs. 8 To increase retroviral infection The 5Ј LTR is derived from Moloney murine sarcoma virus (MoMSV) including part of the RNA packaging siginto PHSCs, a prerequisite for treatment of Gaucher disease by stem cell gene therapy, alternative transduction nal (for a detailed description of the IG-GC vectors described here see Ref. 16 ). The remaining 3Ј part of the methods, culture conditions and retroviral vectors are being explored (see Ref. 9 for a detailed coverage of alterpackaging signal and other 3Ј sequences upstream of the ATG of the inserted transgene are derived from MoMLV. native retroviral transduction methods). To study alternative PHSC transduction methods we generated four difIn the latter part of the vector the ATG gag has been mutated to a TAG and a cryptic splice acceptor site is ferent recombinant retroviral producer cell lines. The recombinant viruses carry either a full-length version of present. After one round of replication the 5Ј LTR driving expression of the transgene will contain the U3 and R the human glucocerebrosidase cDNA or a 3Ј-truncated region derived from the 3Ј LTR carrying the mutant polyoma enhancer PyF101. Therefore, in both IG-GC2 and IG-GC4, transcription of the hGC cDNA is under the control GC4 contains a 160 bp deletion in the 3Ј untranslated producer cell clones contain the intact mutant PyF101 enhancer element. Genomic DNA was extracted from the region of the hGC cDNA. As expected, the difference in length of the hGC cDNAs is sufficient to discriminate producer clones using standard techniques. 18 The isolated DNA was digested with either NheI or with SstI. between the constructs (Figure 1 ).
Virus producing cell clones were generated by cotransWith these two enzymes the presence of the mutant PyF101 enhancer can be investigated in both the 5Ј and fecting ecotropic packaging cell lines with IG-GC2 or IG-GC4 and a neomycin resistance plasmid. Ecotropic virus 3Ј LTR (Figure 2 ). When blotted and probed with the PyF101 fragment, hybridization signals corresponding to was used to infect the amphotropic retroviral packaging cell line, PA317 10 and the Gibbon ape leukemia virus the expected proviral DNA fragments of 3.4 (IG-GC2) or 3.2 kb (IG-GC4) were detected, confirming that the (GaLV) packaging cell line, PG13. 11 Both an increase in hGC activity and Western analysis demonstrated the PyF101 enhancer is present in all four producer cell lines in both the 5Ј and 3Ј LTR (Figure 2 ). Additional hybridizpresence of the hGC protein (data not shown). From each producer pool, more than a hundred cell clones were ing fragments represent flanking genomic DNA sequences. screened for production of hGC transferring virus. 17 Clones were isolated and coded PA2 (PA317/IG-GC2),
To determine a functional virus titer from the PA2, PA4, PG2 and PG4 virus producer cell lines, genomic PA4 (PA317/IG-GC4), PG2 (PG13/IG-GC2) and PG4 (PG13/IG-GC4 , the producer cells were subjected to DNA fingerprinting and provirus-specific identity testing using PCR and and 8 × 10 4 for PA2, PA4, PG2 and PG4, respectively ( Figure 3 ). In addition, the virus titer derived from the Southern analysis. In addition, clinical lots of virus supernatant were tested for endotoxin levels and general PA2 producer cell clone was also determined on NIH/3T3 cells using a different approach 19 and found to safety. Both the master cell banks and clinical lots passed all safety tests. be 6 × 10 5 functional virus particles per milliliter (data not shown). Because it is known that the PyF101 enhancer is less active in fibroblasts compared with the wild-type Gaucher type I and II primary fibroblasts were infected with PA2, PA4, PG2 or PG4 derived virus supernatant. enhancer, 18 we first verified whether the recombinant
Figure 1 (a) Schematic presentation of the proviral structure of IG-GC2 and IG-GC4. Shown are the splice donor (SD), splice acceptor (SA), primer binding sites (P− and P+) and the packaging signal (⌿). Details on vector construction are published elsewhere. 16 The arrows denote the approximate location of oligonucleotides MH3 and GCo4 which are used to discriminate between IG-GC2 and IG-GC4 in a PCR reaction. (b) Ethidium bromide stained gel of PCR results with oligonucleotides MH3 and GCo4 obtained by mixing plasmid IG-GC2 and IG-GC4 in various concentrations (0-100%).
The DNA isolation procedure for PCR analysis has been described. 4 (n = 12), correction levels of approximately 50-70% of normal were achieved. Human GC expression was further confirmed using Western analysis ( Figure 5 ). Therefore, all four producer cell lines generate retrovirus particles that transfer an active hGC gene to primary human cells and are capable of stably correcting the Gaucher defect.
PCR analysis on transduced myeloid cells derived from CD34 + bone marrow cells or individual CFU-GM-derived colonies was performed directly using this suspension. Oligonucleotides GCo4 (5Ј-CAGCCCATGTTCTACCAC-3Ј) and MHo3 (5Ј-GGATCCCTAGGCTTTTGC-3Ј) detect the presence of both IG-GC2 and IG-GC4 provirus.

Figure 2 Southern analysis to assay for the presence of the polyoma enhancer in both the 5Ј and 3Ј LTR. Genomic DNA of the retroviral producer cell lines PA2, PA4, PG2 and PG4 as well as from the parental cell lines PA317 (PA) and PG13 (PG) was isolated. After digestion with either NheI (N) or SstI (S) the genomic DNA was blotted and probed with the complete PyF101 enhancer fragment. For the IG-GC2 construct, present in PA2 and
After informed consent, bone marrow cells were harvested from healthy donors (n = 7), from a patient undergoing allogeneic bone marrow transplantation for NHL (n = 1), and from a patient with Gaucher disease, who underwent surgery for implantation of a porth-acath catheter (n = 1). Peripheral blood stem cells were harvested after mobilization with chemotherapy followed by G-CSF treatment in patients with NHL (n = 3). Low density mononuclear cells (Ͻ1.064 g/cm 3 ) were obtained by Ficoll gradient separation. 21 Human CD34 + cells were isolated using either immunoabsorption columns (Cellpro, Bothell, WA, USA) or magnetic antibodies (Miltenyi, Bergisch Gladbach, Germany). Mononuclear cells or purified CD34 + cells were infected daily for 4 days in the presence of 4 g/ml protamine sulphate the MDR construct is identical to the IG-GC series and
(PG2) and 0.2 (PG4).
the virus titer was approximately 10 5 particles per milliliter as established by vincristine resistance on A2780 cells (unpublished results). Oligonucleotides GCo4 After 48 h their hGC activity was determined using stan-(5Ј-CAGCCCATGTTCTACCAC-3Ј) and MHo3 (5Ј-dard techniques (Figure 4) . 17, 20 Based on these results we GGATCCCTAGGCTTTTGC-3Ј) were used for PCR concluded that a single infection with either PA2 or PG2 analysis on a suspension of mature myeloid cells derived virus supernatant (n = 12) augmented hGC activity levels from transduced CD34 + cells and CFU-GM and prepared in both the Gaucher type I and type II fibroblasts to levels as described previously. 4 comparable with normal human fibroblasts. After transduction with either PA4 or PG4 virus supernatant In Table 1 the results from 11 independent transduc- unknown at present but long-term in vivo transduction cells have shown increases in hGC enzyme levels to a level approximately three-fold higher than normal hGC studies in baboons and rhesus monkeys indicate that GaLV is not superior to amphotropic virus in transducing levels. 1, 19 Based on transduction efficiency and levels of expression, we conclude that the recombinant hGC PHSCs. 24 The overall transduction results shown here are similar to those reported in other studies in which normal viruses we have generated are as efficient in infecting human CD34 + hemopoietic cells as other retroviral vecbone marrow or mobilized peripheral blood was transduced with a hGC retroviral vector. 25 tors for Gaucher disease including MFG-GC and LGC. A comparative study between MFG-GC and LGC-derived Three of our four recombinant retroviruses were also tested for their ability to correct ␤-glucocerebrosidase recombinant viruses indicated that MFG-transduced cells contained approximately five-fold higher levels of spliced deficiency in cells derived from CD34
+ cells of a Gaucher type I patient. Correction of the Gaucher phenotype was RNA per vector copy compared with the LN vectors, suggesting that MFG retroviral vectors provide higher levels clearly achieved in the mature myeloid progeny when compared with the averaged hGC activity measured in of expression in target cells. 26 In the IG-GC2 and IG-GC4 vectors, the splice donor and splice acceptor are both the progeny of eight different CD34 + samples derived from normal donors (Figure 6 ). PCR and subsequent derived from the LN vector. One major difference between the LN vector and IG-GC is the presence of the Southern analysis on the transduced myeloid progeny of the Gaucher CD34
+ cells confirmed the presence of the mutant PyF101 polyoma enhancer in the virus LTRs which might explain the levels of expression measured IG-GC2 and IG-GC4 provirus. The CFU-GM-based retroviral transduction efficiency in the Gaucher-derived in differentiated CD34 + cells. To determine whether we could increase retroviral CD34 + cells, was up to 52% ( Figure 6 ). Although the number of vector-positive CFU-GM between amphotropic transduction using centrifugation, NIH/3T3 cells were infected for 2.5 h at 1100 g (n = 5). A typical example of and GaLV was similar, a comparison between Southern hybridization signals suggested that more copies of the results obtained with diluted PA2 virus is given in Figure 7 . From these results it can be concluded that IG-GC2 construct are present per c.f.u. when PG2 virus was used. This difference in copy number could explain without centrifugation a 50-fold dilution in virus titer results in a complete reduction in hGC activity from the difference in hGC activity measured in the mature myeloid progeny. Studies by others using a hGC retro-375 ± 22 arbitrary hGC units to 0 units. In contrast, using centrifugation, a 50-fold dilution in virus titer results in virus and supernatant transduction of Gaucher CD34 + activity are summarized in Table 2 . These results indicate that four times centrifugation of our undiluted virus preparations on to CD34
+ cells did not result in increased numbers of vector-positive CFU-GM. Evidently the virus concentration was already sufficient for efficient CD34 + cell transduction. This is further witnessed by the finding that a single exposure to undiluted retrovirus preparations, with or without centrifugation, is almost as efficient as four exposures during 4 days. It is generally accepted that centrifugation does not act on the virus to target cell ratio but that it promotes virus-cell contact which increases the chance of successful retroviral uptake in target cells. 27 Since we did not observe increases in retroviral infection of NIH/3T3 cells (data not shown) and human CD34
+ cells using undiluted virus preparations, we conclude that virus binding is not a limiting factor in our recombinant virus preparations.
In summary, we have developed a panel of retroviral vectors carrying the hGC cDNA driven by an LTR containing the mutant polyoma enhancer PyF101 which is known to give sustained expression in human hemopoietic cells. No replication competent retrovirus could be detected in any of the four master cell banks nor was there any RCR detectable in 5% of 10 liter lots of retrovirus produced by two of the cell lines, namely PA2 (PA317 derived) and PG4 (PG13 derived). This is in line with previous observations using PA317 and a construct similar to IGGC2 or IGGC4 but containing the human MDR1 cDNA instead of the hGC cDNA (JJB Boesen, unpublished observations). The recombinant viruses are able to infect human hemopoietic CD34
+ cells efficiently therefore, that our recombinant PA2, PA4 and PG2, and PG4 viruses are ideally suited for gene marking studies to compare the effect of virus tropism within one stem cell graft. Transduction of one stem cell graft with two viruses is preferred to exclude differences in transduction a less than two-fold reduction in hGC activity (from efficiency due to differences in the composition of a retro-355 ± 64 arbitrary hGC units to 205 ± 14). Therefore, cenviral supernatant lot. Components which might negatrifugation for 2.5 h at 1100 g increases the retroviral tively influence transduction of human CD34 + cells are transduction efficiency of diluted virus preparations on physical parameters such as pH, nutrient concentrations NIH/3T3 cells. and concentrations of certain (murine) growth factors The next step was to demonstrate increased transducknown to act on human cells, such as TGF-␤. 28, 29 Upon tion of human CD34
+ cells using the centrifugation protoreinfusion of the transduced stem cell graft, PCR analysis col. For this purpose human CD34
+ cells were seeded in on blood samples will determine which of the two virus supernatant supplemented with protamine-HCl viruses is present more abundantly and hence, which and IL-3 and subsequently centrifuged for 2.5 h at 1100 g retroviral receptor, GLVR-1 or GLVR-2, is expressed either once or four times for 4 days. Analysis of transducmore abundantly on PHSCs. These recombinant viruses tion efficiency into human CD34 + cells is as described can also be used to determine which ex vivo PHSC culture previously. A comparison of the total number of c.f.u.s conditions or transduction protocols are superior. In such obtained by seeding equal numbers of CD34 + cells after studies a stem cell graft will have to be split after which transduction, with or without centrifugation, indicated each graft will be transduced with one virus only. Finally no increased cell death due to the 1100 g centrifugation these retroviruses provide essential ingredients for pilot force (data not shown). The results obtained on the number of vector-positive CFU-GM and increased hGC trials in Gaucher patients. 
